Integrated Diagnostics Holdings plc
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| IDGXF | IMDX | EDT.TO | BDSX | ICLR | DGX | |
|---|---|---|---|---|---|---|
| Market cap | 341.24M | 92.61M | 293.55M | 223.47M | 14.29B | 26.70B |
| P/E (TTM) | 11.7 | — | — | — | 195.0 | 25.2 |
| Forward P/E | — | -3.5 | 50.0 | -96.3 | 15.7 | 20.1 |
| Price/book | 0.1 | -4.3 | -4.2 | 24.4 | 1.5 | 3.7 |
| Dividend yield | 1.45% | — | — | — | — | 1.41% |
| 1-year change | +10.75% | −57.16% | −29.87% | +255.72% | +4.11% | +33.54% |
| Today | 0.00% | −0.35% | −7.41% | −11.53% | −0.09% | −0.57% |
The closest companies by business and industry (Diagnostics & Research). Prices may be delayed up to 15 min.
Latest news
All IDGXF news ›Prenosis Announces $20M BARDA Contract and $20M Series A Financing Round, Advancing Mission to Deliver Integrated Diagnostics and Therapeutics
Jan 29, 2026, 10:05 ET Bobby Reddy, Jr., PhD, Prenosis CEO and co-founder explains, "Because of these investments, we are well-positioned to advance the development of biology-driven solutions that can transform outcomes for patients…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
newspatrolling.com1
-
prnewswire.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.